ArticleCancers2021
NRF2 Activation Confers Resistance to eIF4A Inhibitors in Cancer Therapy.
Viraj R Sanghvi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this papercites it
ArticleCancers2021
Viraj R Sanghvi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.